Sickle Cell Disease
4 competing products in clinical development for Sickle Cell Disease.
Pipeline by Phase
Phase 11
Phase 22
Phase 31
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Prasugrel | Daiichi Sankyo | Phase 2 | Completed | 35 |
| Placebo + Dalteparin | Eisai | Phase 2 | Completed | 35 |
| Prasugrel + Placebo | Daiichi Sankyo | Phase 3 | Terminated | 32 |
| Lexiscan | Astellas Pharma | Phase 1 | Completed | 29 |